BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12561346)

  • 21. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of porous lamellar poly(L-lactic acid) scaffolds by conventional injection molding process.
    Ghosh S; Viana JC; Reis RL; Mano JF
    Acta Biomater; 2008 Jul; 4(4):887-96. PubMed ID: 18396473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optimization of preparation parameters for gentamicin-loaded PLLA nanoparticles and the drug release behavior in vitro].
    He Z; Xing J; Kong H; Xu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Apr; 26(2):351-5. PubMed ID: 19499801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface modification of poly(L-lactic acid) membrane via layer-by-layer assembly of silver nanoparticle-embedded polyelectrolyte multilayer.
    Yu DG; Lin WC; Yang MC
    Bioconjug Chem; 2007; 18(5):1521-9. PubMed ID: 17688319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of biodegradable liquid core PLLA microcapsules and hollow PLLA microcapsules using microfluidics.
    Lensen D; van Breukelen K; Vriezema DM; van Hest JC
    Macromol Biosci; 2010 May; 10(5):475-80. PubMed ID: 20336699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of azacytidine/poly(L-lactic) acid particles prepared by supercritical antisolvent precipitation.
    Argemí A; Vega A; Subra-Paternault P; Saurina J
    J Pharm Biomed Anal; 2009 Dec; 50(5):847-52. PubMed ID: 19660889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
    Lu J; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering.
    Wei G; Ma PX
    Biomaterials; 2004 Aug; 25(19):4749-57. PubMed ID: 15120521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint.
    Liang LS; Jackson J; Min W; Risovic V; Wasan KM; Burt HM
    J Pharm Sci; 2004 Apr; 93(4):943-56. PubMed ID: 14999731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface characteristics of holmium-loaded poly(L-lactic acid) microspheres.
    Zielhuis SW; Nijsen JF; Figueiredo R; Feddes B; Vredenberg AM; van het Schip AD; Hennink WE
    Biomaterials; 2005 Mar; 26(8):925-32. PubMed ID: 15353204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratins extracted from Merino wool and Brown Alpaca fibres: thermal, mechanical and biological properties of PLLA based biocomposites.
    Fortunati E; Aluigi A; Armentano I; Morena F; Emiliani C; Martino S; Santulli C; Torre L; Kenny JM; Puglia D
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():394-406. PubMed ID: 25492212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spiropyran-based X-ray sensitive fiber.
    Kinashi K; Miyamae Y; Nakamura R; Sakai W; Tsutsumi N; Yamane H; Hatsukano G; Ozaki M; Jimbo K; Okabe T
    Chem Commun (Camb); 2015 Jun; 51(56):11170-3. PubMed ID: 26066026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles.
    Ueda M; Iwara A; Kreuter J
    J Microencapsul; 1998; 15(3):361-72. PubMed ID: 9608398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propane-1,2-diols from dilactides, oligolactides, or poly-L-lactic acid (PLLA): from plastic waste to chiral bulk chemicals.
    Shuklov IA; Dubrovina NV; Schulze J; Tietz W; Kühlein K; Börner A
    Chemistry; 2014 Jan; 20(4):957-60. PubMed ID: 24403172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uniaxial drawing and mechanical properties of poly[(R)-3-hydroxybutyrate]/poly(L-lactic acid) blends.
    Park JW; Doi Y; Iwata T
    Biomacromolecules; 2004; 5(4):1557-66. PubMed ID: 15244478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
    Liu M; Li H; Luo G; Liu Q; Wang Y
    Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.